☆ 4.5 Review

Glypican-3: From the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)

Journal

EXPERIMENTAL AND MOLECULAR PATHOLOGY

Volume 82, Issue 2, Pages 184-189

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

DOI: 10.1016/j.yexmp.2006.10.010

Keywords

glypican-3; liver cancer; hepatocellular carcinoma; tumor marker; immunohistochemistry

Categories

Pathology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.